Pipeline > Overview
Acacia Pharma has generated a pipeline of product opportunities addressing a range of supportive care indications using a commercially driven approach to product discovery that identifies new uses for known marketed drugs.
This lower risk strategy leads to product opportunities with a higher probability of success and enables rapid clinical proof-of concept. In addition, Acacia Pharma’s products are expected to reach the market quickly given that they are based on the novel use of well-characterised pharmaceuticals.
